Virtus Biotech ETF-UsdBBPETF

13F holders, Q3 2025 (September 30)
16holders +1
2new positions
1sold out
1famous investor
$70.03avg. 13F price*

At the end of Q3 2025, 16 institutions reported holding Virtus Biotech ETF-Usd Inc. (BBP) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Jane Street Group, LLC ($2.2M), Susquehanna International Group, LLP ($2.0M) and CWA Asset Management Group, LLC ($1.7M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Virtus Biotech ETF-Usd Inc.
Filed as
ETFIS SER TR I (Q3 2025)
CUSIP
26923G202
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 14Q1 2024Q2 2024: 13Q2 2024Q3 2024: 14Q3 2024Q4 2024: 13Q4 2024Q1 2025: 13Q1 2025Q2 2025: 15Q2 2025Q3 2025: 16Q3 2025Q4 2025: 20Q4 2025Q1 2026: 26Q1 2026Q2 2026: 25Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions2$12K
Exits1$33K

All 13F filers, Q2 2025 → Q3 2025: 23,792 shares bought and 13,082 shares sold, net +10,710 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 16 holders

Jane Street Group, LLC 0.00% Add +66.7% 30,836 $2.2M
Susquehanna International Group, LLP 0.00% Add +1.6% 28,960 $2.0M
CWA Asset Management Group, LLC 0.06% Add +3.2% 23,746 $1.7M
Citadel Advisors 0.00% Add +110.0% 14,953 $1.0M
Morgan Stanley 0.00% Reduce -5.3% 14,371 $1.0M
Independent Financial Group, LLC 0.01% Add +0.3% 7,128 $499K
Flow Traders U.S. LLC 0.02% Reduce -10.7% 6,613 $463K
Raymond James Financial Inc. 0.00% Reduce -62.6% 6,518 $456K
LPL Financial LLC 0.00% Add +47.7% 6,238 $436K
Wealth Enhancement Advisory Services, LLC 0.00% No change 5,070 $363K
Cetera Investment Advisers 0.00% Add +4.5% 4,891 $342K
Cwm, LLC 0.00% No change 717 $50K
Osaic Holdings, Inc. 0.00% No change 450 $31K
Comerica Bank 0.00% New 106 $7K
Allworth Financial LP 0.00% New 71 $5K
Glen Eagle Advisors, LLC 0.00% No change 50 $3K

"% of holder's portfolio" is BBP's weight in each manager's 13F, not the share of Virtus Biotech ETF-Usd Inc. the manager owns.